메뉴 건너뛰기




Volumn 118, Issue 4, 2012, Pages 981-986

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Author keywords

clinical trial design; germ cell tumors; overall survival; phase II trial; progression free survival; relapsed or refractory

Indexed keywords

2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE; IXABEPILONE; RETINOIC ACID; SUNITINIB; SURAMIN; TEMOZOLOMIDE; TOPOTECAN; ALL TRANSRETINOIC ACID; BLEOMYCIN; CISPLATIN; ETOPOSIDE; PACLITAXEL; RETINOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

EID: 84856772146     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26375     Document Type: Article
Times cited : (55)

References (16)
  • 1
    • 39049120759 scopus 로고    scopus 로고
    • Medical treatment of advanced testicular cancer
    • Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ,. Medical treatment of advanced testicular cancer. JAMA. 2008; 299: 672-684.
    • (2008) JAMA , vol.299 , pp. 672-684
    • Feldman, D.R.1    Bosl, G.J.2    Sheinfeld, J.3    Motzer, R.J.4
  • 3
    • 3142577828 scopus 로고    scopus 로고
    • Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
    • Kollmannsberger C, Beyer J, Liersch R, et al. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol. 2004; 22: 108-114.
    • (2004) J Clin Oncol , vol.22 , pp. 108-114
    • Kollmannsberger, C.1    Beyer, J.2    Liersch, R.3
  • 4
    • 33749235727 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor
    • discussion 38-39
    • De Giorgi U, Rosti G, Aieta M, et al. Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor. Eur Urol. 2006; 50: 1032-1038; discussion 38-39.
    • (2006) Eur Urol , vol.50 , pp. 1032-1038
    • De Giorgi, U.1    Rosti, G.2    Aieta, M.3
  • 5
    • 11144355665 scopus 로고    scopus 로고
    • Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: A phase II study
    • Pectasides D, Pectasides M, Farmakis D, et al. Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study. Ann Oncol. 2004; 15: 493-497.
    • (2004) Ann Oncol , vol.15 , pp. 493-497
    • Pectasides, D.1    Pectasides, M.2    Farmakis, D.3
  • 6
    • 0025141586 scopus 로고
    • Phase II study of daily oral etoposide in refractory germ cell tumors
    • Miller JC, Einhorn LH,. Phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol. 1990; 17 (1 suppl 2): 36-39.
    • (1990) Semin Oncol , vol.17 , Issue.1 SUPPL. 2 , pp. 36-39
    • Miller, J.C.1    Einhorn, L.H.2
  • 8
    • 0026731918 scopus 로고
    • Phase II trial of suramin in patients with advanced renal cell carcinoma: Treatment results, pharmacokinetics, and tumor growth factor expression
    • Motzer RJ, Nanus DM, O'Moore P, et al. Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression. Cancer Res. 1992; 52: 5775-5779.
    • (1992) Cancer Res , vol.52 , pp. 5775-5779
    • Motzer, R.J.1    Nanus, D.M.2    O'Moore, P.3
  • 9
    • 0028984044 scopus 로고
    • All-trans retinoic acid for treating germ cell tumors. in vitro activity and results of a phase II trial
    • Moasser MM, Motzer RJ, Khoo KS, et al. all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial. Cancer. 1995; 76: 680-686.
    • (1995) Cancer , vol.76 , pp. 680-686
    • Moasser, M.M.1    Motzer, R.J.2    Khoo, K.S.3
  • 10
    • 0028860716 scopus 로고
    • Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors
    • Puc HS, Bajorin DF, Bosl GJ, Amsterdam A, Motzer RJ,. Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors. Invest New Drugs. 1995; 13: 163-165.
    • (1995) Invest New Drugs , vol.13 , pp. 163-165
    • Puc, H.S.1    Bajorin, D.F.2    Bosl, G.J.3    Amsterdam, A.4    Motzer, R.J.5
  • 11
    • 0033894907 scopus 로고    scopus 로고
    • Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
    • Vuky J, McCaffrey J, Ginsberg M, et al. Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors. Invest New Drugs. 2000; 18: 265-267.
    • (2000) Invest New Drugs , vol.18 , pp. 265-267
    • Vuky, J.1    McCaffrey, J.2    Ginsberg, M.3
  • 12
    • 10744223010 scopus 로고    scopus 로고
    • Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors
    • Kondagunta GV, Bacik J, Schwartz L, et al. Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors. Invest New Drugs. 2004; 22: 177-179.
    • (2004) Invest New Drugs , vol.22 , pp. 177-179
    • Kondagunta, G.V.1    Bacik, J.2    Schwartz, L.3
  • 13
    • 34547702867 scopus 로고    scopus 로고
    • Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    • Feldman DR, Kondagunta GV, Ginsberg MS, et al. Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors. Invest New Drugs. 2007; 25: 487-490.
    • (2007) Invest New Drugs , vol.25 , pp. 487-490
    • Feldman, D.R.1    Kondagunta, G.V.2    Ginsberg, M.S.3
  • 14
    • 77956621875 scopus 로고    scopus 로고
    • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    • Feldman DR, Turkula S, Ginsberg MS, et al. Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Invest New Drugs. 2010; 28: 523-528.
    • (2010) Invest New Drugs , vol.28 , pp. 523-528
    • Feldman, D.R.1    Turkula, S.2    Ginsberg, M.S.3
  • 15
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R,. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989; 10: 1-10.
    • (1989) Control Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 16
    • 0034018538 scopus 로고    scopus 로고
    • Results of treatment after relapse from high-dose chemotherapy in germ cell tumors
    • Porcu P, Bhatia S, Sharma M, Einhorn LH,. Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. J Clin Oncol. 2000; 18: 1181-1186.
    • (2000) J Clin Oncol , vol.18 , pp. 1181-1186
    • Porcu, P.1    Bhatia, S.2    Sharma, M.3    Einhorn, L.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.